Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. - Goeters,C.; Wenn,A.; Mertes,N.; Wempe,C.; Van Aken,H.; Stehle,P.; Bone,H.G. (Crit Care Med, 2002)